超声技术在乳腺癌新辅助化疗疗效评估中的应用进展

Application Progress of Ultrasound in Efficacy Evaluation of Neoadjuvant Chemotherapy for Breast Cancer

乳腺癌是全球女性发病率最高的恶性肿瘤之一,严重影响女性的身心健康。随着新辅助化疗(NAC)在乳腺癌治疗中的广泛应用,准确评估其疗效可以为乳腺癌的治疗和预后提供重要信息。因此,可量化疾病反应的超声技术对于评估接受NAC的患者至关重要。常规超声是乳腺癌诊断的主要手段,超微血管成像、三维超声成像等技术在评估乳腺癌NAC疗效方面的优势显著。因此,全面了解超声技术在乳腺癌NAC疗效评估中的作用,可以为疾病的治疗提供新思路。

Breast cancer is one of the most common malignant tumors in women worldwide,which seriously affects women′s physical and mental health.With the widespread use of neoadjuvant chemotherapy(NAC)in the treatment of breast cancer,an accurate assessment of its efficacy can provide important information for the treatment and prognosis.Therefore,ultrasound techniques that can quantify disease response are essential for the evaluation of patients receiving NAC.Conventional ultrasound is the main means of breast cancer diagnosis,and ultramircovascular imaging,three-dimensional ultrasound imaging and other technologies have significant advantages in evaluating the efficacy of NAC for breast cancer.Therefore,a comprehensive understanding of the role of ultrasound technology in the evaluation of the efficacy of NAC for breast cancer can provide new ideas for the treatment of the disease.